Autosomal dominant cerebellar ataxia type II is a rare inherited neurologic condition that affects balance, coordination, and eye movements. People with this condition often develop unsteady walking, clumsy hands, and vision problems like nystagmus or trouble tracking, with early symptoms of autosomal dominant cerebellar ataxia type II usually starting in adolescence or adulthood. It is typically lifelong and slowly progressive, and not everyone will have the same experience. Doctors describe this as a genetic disorder passed in families, and children of an affected parent have a 50% chance of inheriting it. Treatment focuses on symptom management with physical and occupational therapy, vision support, fall prevention, and sometimes medicines for tremor or stiffness, and most people live many years with careful care and safety planning.
Overview
Autosomal dominant cerebellar ataxia type iiSymptoms
In autosomal dominant cerebellar ataxia type II, symptoms include unsteady walking, poor balance, slurred speech, and clumsiness. Many develop worsening vision from retinal damage. Symptoms often progress and may include swallowing trouble and eye movement problems.
Outlook and prognosis
Many living with autosomal dominant cerebellar ataxia type II notice a slow, years-long change in balance, coordination, and speech. Progression varies by family and gene change. Regular neurologic care, targeted therapies, and mobility support can maintain function and independence.
Causes and risk factors
Autosomal dominant cerebellar ataxia type II is caused by a single gene change passed in an autosomal-dominant pattern or arising as a new mutation. The key risk is having an affected parent. Alcohol, sedatives, and toxins may worsen symptoms.
Genetic influences
Genetics are central in Autosomal dominant cerebellar ataxia type II. A single altered gene, inherited from one parent, typically causes the condition, with 50% transmission risk per child. Variants influence age of onset, progression, and associated features.
Diagnosis
Doctors start with neurologic exam, family history, and balance/eye-movement testing. Brain MRI looking for cerebellar changes plus targeted genetic tests confirm the genetic diagnosis of Autosomal dominant cerebellar ataxia type ii.
Treatment and drugs
Treatment for autosomal dominant cerebellar ataxia type II focuses on easing symptoms and supporting daily function. Care often includes physical and balance therapy, speech therapy, vision care, migraine prevention, and medicines for tremor or stiffness. Regular neurologist follow-up and genetic counseling help guide long-term planning.
Symptoms
Balance and coordination changes often stand out in daily life—walking feels less steady, and tasks like buttoning a shirt take more care. It can also affect vision, making reading or recognizing faces harder and dim settings more challenging. Some early features of autosomal dominant cerebellar ataxia type II show up as small shifts in balance and hand control during everyday tasks. Features vary from person to person and can change over time.
In autosomal dominant cerebellar ataxia type II, balance can feel unpredictable, leading to a wider, slower walk. Uneven ground or crowded spaces can raise the risk of stumbles or falls.
Buttons, keys, or touchscreens may be harder to manage. Handwriting can look larger or shakier, and reaching for a target may overshoot or miss.
Speech may sound slurred or slow, especially after long conversations. Friends may ask you to repeat yourself more often.
Liquids can go down the wrong way, causing coughing or choking. Meals can take longer and feel less comfortable.
How people usually first notice Autosomal dominant cerebellar ataxia type ii?
People often notice the first signs of autosomal dominant cerebellar ataxia type II as a gradual change in balance and coordination—unsteady walking, frequent stumbles, or trouble with fine tasks like buttoning—typically starting in adolescence or adulthood. Some also develop slurred speech and shaky eye movements, and a family history of similar symptoms can make how autosomal dominant cerebellar ataxia type II is first noticed clearer. Because symptoms progress slowly, many first seek care after falls or when everyday activities feel noticeably harder than before.
Types of Autosomal dominant cerebellar ataxia type ii
Autosomal dominant cerebellar ataxia type II is a genetic condition with recognized clinical variants that can look somewhat different from one another over time. Many living with this condition share balance and coordination problems, but vision, eye movement, and thinking changes can vary by subtype and even within families. The variants are usually defined by the specific gene involved and the pattern of symptoms and age at onset. Not everyone will experience every type.
SCA2 variant
Often begins with unsteady walking and slurred speech in early to mid‑adulthood. People may develop slowed eye movements and, later, hand coordination problems and leg cramps. Some notice tingling or numbness from nerve involvement.
SCA3 (Machado‑Joseph)
Tends to cause balance problems with stiff or spastic legs and hand clumsiness. Eye movement problems and double vision are common over time. Some may have facial twitching or cramps.
SCA6 variant
Usually starts later in adulthood with slowly progressive balance and speech changes. Eye movements can be jerky, and dizziness may flare with quick head turns. Thinking is typically preserved longer than in other types of autosomal dominant cerebellar ataxia type II.
SCA7 variant
Balance problems appear alongside vision changes from retinal involvement. People can notice trouble seeing in dim light and gradual central vision loss. Eye movement control also becomes harder over time.
SCA1 variant
Begins with gait imbalance and slurred speech, often progressing over years. Eye movement control and swallowing can become difficult. Some may notice mild thinking changes as the condition advances.
SCA17 variant
Combines movement and balance problems with earlier thinking and mood changes. Speech can become slow or strained, and movements may feel jerky or restless. Seizures can occur in a subset.
DRPLA variant
Can present with ataxia, involuntary movements, and seizures. Thinking changes and mood symptoms may appear earlier, especially with younger onset. Vision is usually less affected than in SCA7.
Anticipation pattern
In several types of autosomal dominant cerebellar ataxia type II, symptoms start earlier and can be more severe in the next generation. This is linked to repeat expansions in the gene. Families may notice ages of onset shifting over time, a key clue when discussing types of autosomal dominant cerebellar ataxia.
What genetics can tell you about symptoms
Some people with autosomal dominant cerebellar ataxia type II develop unsteady walking, slurred speech, and shaky eye movements because inherited changes in certain genes damage cerebellar nerve cells. Specific variants, like in the ATXN2 gene, often lead to earlier balance problems and gradual coordination loss.
Causes and risk factors
Autosomal dominant cerebellar ataxia type II is caused by an expanded DNA repeat in the ATXN7 gene that is inherited in families. The main risk factor for autosomal dominant cerebellar ataxia type II is having a parent with the condition, and a larger repeat size often leads to earlier onset and more severe symptoms. Doctors distinguish between risk factors you can change and those you can’t. Alcohol misuse and nerve-toxic exposures can worsen symptoms, while regular activity, fall prevention, and good sleep may support function. New mutations are rare, and age at onset varies widely even within one family.
Environmental and biological risk factors
Autosomal dominant cerebellar ataxia type ii usually stems from factors set at conception, and environmental risk factors for autosomal dominant cerebellar ataxia type ii appear limited. Researchers are still exploring how outside influences interact with our inner biology. Below are biological and environmental exposures that could affect the chance of a first-time case without family history; for most families, any added risk is small.
As men age, spontaneous changes can build up in sperm, which can slightly increase the chance of a new change at conception. This makes a first-time case without family history possible but still uncommon.
Age-related changes in eggs can also slightly raise the chance of a new change at conception. Any effect on autosomal dominant cerebellar ataxia type ii appears small overall.
Exposure of the reproductive organs to high-dose ionizing radiation (for example, radiation therapy) can increase changes in sperm or eggs. There is no proven direct link to this condition, and the absolute risk remains very low.
Chemotherapy or radiation before conceiving can sometimes damage sperm or eggs. Most children are healthy, and no clear association with this condition has been shown.
Genetic risk factors
Most genetic risk for this condition comes from a repeat expansion in a single gene that can be passed from a parent. Autosomal dominant cerebellar ataxia type ii is most often linked to an abnormally long CAG repeat in the ATXN7 gene. Family history is important, but age at onset and severity differ because the repeat can change size from one generation to the next. Risk is not destiny—it varies widely between individuals.
Dominant inheritance: In this pattern, one changed gene copy can cause the condition. Each child of an affected parent has a 50% chance to inherit the change that can lead to Autosomal dominant cerebellar ataxia type ii.
ATXN7 gene expansion: A lengthened CAG repeat in the ATXN7 gene is the key genetic cause of Autosomal dominant cerebellar ataxia type ii. When the repeat exceeds a threshold, the gene no longer works normally.
Repeat size matters: Larger repeats are linked to earlier onset and faster progression. This is why early symptoms of Autosomal dominant cerebellar ataxia type ii may appear in younger generations.
Genetic anticipation: The repeat can expand when passed to children, leading to younger age at onset in the next generation. This “anticipation” explains why severity can increase within families.
Parental origin effects: Repeat growth tends to happen more often during sperm formation, so expansions may enlarge with paternal transmission. This can raise the chance of very early onset in offspring.
Reduced penetrance range: Borderline repeat sizes may never cause clear symptoms or may cause very late onset. This means some people carrying the change might not be diagnosed during their lifetime.
De novo expansion: Rarely, a new large repeat develops even when parents seem unaffected, usually from a smaller unstable repeat. In such cases there is no clear family history despite a genetic cause.
Genetic modifiers: Other genes likely nudge the age at onset and severity, but repeat length remains the strongest driver. Research continues to clarify these influences.
Lifestyle risk factors
Autosomal dominant cerebellar ataxia type ii is a genetic condition; lifestyle habits do not cause it, but they can influence symptom control, day‑to‑day function, and complications. Focusing on how lifestyle affects Autosomal dominant cerebellar ataxia type ii may help reduce falls, preserve mobility, and support speech and swallowing. The elements below highlight practical choices that can make a measurable difference.
Alcohol directly impairs cerebellar function and can immediately worsen gait, balance, and slurred speech. Even small amounts may increase fall risk and injury in people with ataxia.
Regular, moderate-intensity cardio can improve endurance and walking capacity in ataxia. It may also help slow functional decline and reduce fatigue during daily tasks.
Targeted balance and coordination work (e.g., tandem stance, tai chi) can improve postural control. This reduces falls and builds confidence moving in complex environments.
Lower-limb and core strengthening can compensate for incoordination by improving stability. Stronger muscles support safer transfers, stairs, and longer walking distances.
Risk prevention
Autosomal dominant cerebellar ataxia type ii is inherited, so you can’t prevent the gene itself. The focus is on reducing complications, protecting vision and mobility, and planning ahead to stay independent. Prevention is about lowering risk, not eliminating it completely. Personalized care, attention to early symptoms of autosomal dominant cerebellar ataxia type ii, and regular check-ins can make daily life steadier.
A genetics visit can explain inheritance, testing options, and family planning choices. It can also help relatives understand their own risks and timing for testing.
See a neurologist and eye specialist to track balance, coordination, and retinal health. Screening catches changes early so care can be adjusted.
Remove tripping hazards, add grab bars, and improve lighting to reduce falls. A physiotherapist or occupational therapist can suggest tailored home changes.
Targeted physiotherapy builds steadiness, leg strength, and reflexes. Consistent practice can lower fall risk and keep daily activities safer.
Transmission
Autosomal dominant cerebellar ataxia type II is not contagious; it doesn’t spread through touch, air, or shared items. It’s passed down in an autosomal dominant pattern, meaning a parent with the condition has a 50% chance of passing the gene change to each child. In some families, especially when the gene change involves a stretch of DNA that can get longer, symptoms may start earlier or be more severe in the next generation—this pattern is called anticipation. New (de novo) changes can appear rarely, so someone may be the first in their family to have it; a genetic counselor can explain how Autosomal dominant cerebellar ataxia type II is inherited and what that may mean for relatives.
When to test your genes
Test your genes if you or close relatives have unexplained balance problems, incoordination, tremor, or slurred speech that began in adulthood, especially across generations. Early testing helps confirm diagnosis, guide surveillance, and tailor therapy and rehabilitation. Consider testing before family planning or when symptoms change.
Diagnosis
When balance problems and vision changes start to affect walking, reading signs, or driving, people often look for answers. In Autosomal dominant cerebellar ataxia type ii, doctors piece together a pattern that links movement issues with eye findings and a family trend across generations. Family history is often a key part of the diagnostic conversation. The genetic diagnosis of Autosomal dominant cerebellar ataxia type ii usually pairs these clinical clues with confirmatory testing.
Doctors check walking, coordination, speech, and eye movements for signs that fit a cerebellar pattern. These clinical features help distinguish ataxia from muscle or nerve problems. They also guide which tests come next.
A dilated eye exam and retinal imaging look for macular or retinal changes that can accompany this condition. Finding these eye features alongside coordination problems raises suspicion for this specific ataxia type. Eye findings can also help track changes over time.
Imaging looks for shrinkage of the cerebellum and sometimes the brainstem. These imaging findings support the diagnosis and help rule out stroke, inflammation, or tumors. MRI results are combined with exam findings and history.
A multigene ataxia panel checks several known genes at once, and targeted testing is used if a family variant is already known. Genetic tests can confirm the suspected cause and clarify risks for relatives. Counselors can help explain results and options.
Stages of Autosomal dominant cerebellar ataxia type ii
Autosomal dominant cerebellar ataxia type ii does not have defined progression stages. The condition can progress over time, but the pace and features vary widely between families and individuals, and it’s identified by clinical findings and genetic testing rather than fixed stage labels. If early symptoms of autosomal dominant cerebellar ataxia type ii—such as unsteady walking, trouble with coordination, or vision changes—raise concern, different tests may be suggested to help confirm the diagnosis, including a neurologic exam, eye evaluation, brain MRI, and targeted genetic testing. Ongoing monitoring usually involves regular follow‑up for balance and speech, vision checks, and functional scales to track day‑to‑day impact, which guides therapy and support.
Outlook and prognosis
Day-to-day, autosomal dominant cerebellar ataxia type II (also called spinocerebellar ataxia type 2) tends to bring gradually worsening balance problems, shaky or uncoordinated movements, slurred speech, and slowed eye movements. The outlook is not the same for everyone, but progression is usually slow over years, not weeks, and many people stay mobile—often with a cane or walker—for a long time. Doctors call this the prognosis—a medical word for likely outcomes. Early symptoms of autosomal dominant cerebellar ataxia type II can start in young adulthood or later in life; earlier onset is generally linked to faster change over time.
Looking at the long-term picture can be helpful. Life span can be reduced in more severe cases, especially with very early onset or when breathing or swallowing become affected, but many people live into later adulthood. Complications to watch for include falls, pneumonia from swallowing difficulties, and unintentional weight loss; addressing these risks early can improve day-to-day function and safety. Some people experience periods where symptoms feel fairly steady, while others notice a slow, stepwise decline.
In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. A known gene change can run in families, and genetic testing can sometimes provide more insight into prognosis, including expected speed of progression. With ongoing care, many people maintain independence in basic activities through physical therapy, speech and swallow support, fall prevention, and treatment of mood or sleep issues. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Autosomal dominant cerebellar ataxia type ii tends to progress over years, affecting coordination, vision, and everyday independence. Long-term effects vary widely, and the pace can differ even within the same family. People may notice early symptoms of autosomal dominant cerebellar ataxia type ii such as unsteady walking and increasing visual difficulties, with other features emerging gradually over time.
Coordination slowly declines and walking becomes less steady. Falls may become more frequent as the years pass.
Progressive retinal damage leads to blurry or dim vision, often with trouble seeing at night. Over time, this can advance to severe vision loss.
Speech may grow slurred and slower. Longer conversations can become tiring and harder for others to follow.
Swallowing can weaken and become uncoordinated. This raises the risk of choking or aspiration pneumonia.
How is it to live with Autosomal dominant cerebellar ataxia type ii?
Living with autosomal dominant cerebellar ataxia type II often means planning your day around balance, coordination, and vision challenges, with tasks like walking on uneven ground, reading, or using fine motor skills taking more time and focus. Fatigue can build quickly, and symptoms may fluctuate, so many people pace activities, use mobility aids when needed, and adapt their homes and routines to stay safe and independent. Family, friends, and coworkers may notice slower movement or slurred speech; clear communication, patience, and practical support—like unhurried conversations, handrails, and help with transportation—can make a big difference. Over time, partnering with neurology, rehabilitation therapists, and low-vision or speech specialists helps people maintain function and confidence, while loved ones learn how to support without taking over.
Treatment and drugs
Treatment for autosomal dominant cerebellar ataxia type II focuses on easing symptoms, maintaining mobility, and supporting day-to-day function, since no cure or disease‑slowing drug is established yet. Physical and occupational therapy help with balance, coordination, and home safety, while speech therapy can support clear speech and safe swallowing if those are affected. Doctors may try medicines used for ataxia symptoms—such as agents that reduce tremor, muscle stiffness, dizziness, or neuropathic pain—and a doctor may adjust your dose to balance benefits and side effects. Alongside medical treatment, lifestyle choices play a role, including regular targeted exercise, fall‑prevention strategies, vision support for associated eye movement problems, and tools like canes, walkers, or weighted utensils. Genetic counseling, mental health support, and periodic review with a neurologist familiar with ataxia are recommended, and research is ongoing into new therapies and clinical trials.
Non-drug treatment
Living with Autosomal dominant cerebellar ataxia type ii (ADCA II) often affects walking, balance, speech, and vision in day-to-day life. Early symptoms of Autosomal dominant cerebellar ataxia type ii can include unsteady steps and subtle changes in seeing fine details or low contrast. Non-drug treatments often lay the foundation for staying independent, improving safety, and adapting to changing abilities. These approaches can be tailored to your goals and may change over time as needs evolve.
Targeted exercises build strength, balance, and coordination to steady your gait. Therapists can progress your plan safely and track improvements over time.
Structured balance work reduces falls and boosts confidence when moving around. This may include standing drills, weight shifts, and walking on different surfaces.
Everyday tasks are broken into safer, simpler steps to protect energy and independence. Therapists suggest tools and layouts that make dressing, cooking, and work easier.
Speech-language therapy improves speech clarity and safer swallowing. Techniques and exercises can lower choking risk and make meals less stressful.
Your genes may have an impact on how drugs work for you
Medicines for autosomal dominant cerebellar ataxia type II can work differently depending on variants in genes that affect how your body absorbs, breaks down, and responds to drugs. Pharmacogenetic testing may guide dose choices and side‑effect risk, but clinical monitoring still leads.
Pharmacological treatments
Medicines for autosomal dominant cerebellar ataxia type ii focus on easing symptoms that affect walking, vision steadiness, tremor, mood, sleep, and nerve pain. Treatment is tailored to what gets in the way of daily life, including early symptoms of autosomal dominant cerebellar ataxia type ii like imbalance or shaky vision. Not everyone responds to the same medication in the same way. Many options are tried in sequence or combined carefully to balance benefit and side effects.
Can ease slowness, stiffness, and tremor when parkinsonian features occur in this condition. Some people with autosomal dominant cerebellar ataxia type ii notice better stride length and smoother movements.
Small studies suggest modest improvement in coordination and gait in cerebellar ataxias. Side effects can include fatigue or nausea, and periodic liver blood tests may be needed.
An investigational form related to riluzole being studied for spinocerebellar ataxias. Access is typically through clinical trials, and your neurology team can advise if it’s suitable.
May reduce downbeat nystagmus (bouncing vision) and help steadiness for some people. Doses are individualized, and it is avoided in those with a history of seizures.
Genetic influences
Autosomal dominant cerebellar ataxia type II is typically inherited in a dominant way: if a parent has it, each child has about a 1 in 2 chance (50%) of inheriting the gene change. Most families have a change in a gene called ATXN7, where an abnormal stretch of DNA repeats more times than it should. That repeat can grow when it’s passed to the next generation, a pattern called anticipation, which can bring an earlier start and faster progression in children than in their parent. In general, a longer repeat is linked to a higher chance of symptoms and an earlier age at which early symptoms of autosomal dominant cerebellar ataxia type II may appear, but there’s still wide variation even within the same family. DNA testing can sometimes identify these changes. Because results can affect relatives and family planning, genetic counseling is recommended to discuss risks, testing options, and what results might mean for you and your family.
Is Autosomal dominant cerebellar ataxia type ii genetic?
Genetics are central in Autosomal dominant cerebellar ataxia type II. A single altered gene, inherited from one parent, typically causes the condition, with 50% transmission risk per child. Variants influence age of onset, progression, and associated features.
Pharmacogenetics—how genetics influence drug effects
Genes can shape two parts of care: the condition itself and how your body handles medicines. Pharmacogenetics is the study of how genes influence your response to medicines, including how much you need and the risk of side effects. In Autosomal dominant cerebellar ataxia type ii, the inherited change that causes the disease can shape the early symptoms of Autosomal dominant cerebellar ataxia type ii—such as balance problems or vision changes—and that, in turn, guides which drugs are used and what to watch for. Separate genetic differences in liver enzymes can change how quickly you break down common treatments for stiffness, tremor, mood, or pain, so doses sometimes need to be lower or higher than average. If you process a drug slowly, even usual doses can bring more side effects; if you clear it quickly, you may not get enough benefit. Your doctor may combine your medical history with gene test results, when available, to choose a safe starting dose or switch drugs if side effects show up. Still, genes are only part of the story—your age, liver and kidney function, and other prescriptions also affect how you respond, so results guide care but don’t replace careful monitoring.
Interactions with other conditions
Living day-to-day with autosomal dominant cerebellar ataxia type ii (ADCA II) can be harder when other health issues affect balance, vision, or nerves. A condition may “exacerbate” (make worse) symptoms of another, so things like diabetic neuropathy, vestibular disorders (inner ear balance problems), or separate eye diseases such as cataracts or macular degeneration can add to unsteadiness and visual strain. People sometimes confuse early symptoms of autosomal dominant cerebellar ataxia type ii with medication side effects or diabetic nerve changes, which can delay helpful evaluations. Sedating medicines, some anti-seizure drugs, and alcohol can intensify slurred speech or poor coordination, while blood pressure medicines that cause dizziness may increase fall risk. Mood conditions like anxiety or depression can also interact with ADCA II by reducing activity and rehabilitation participation, and sleep apnea can worsen daytime fatigue and balance. Coordinated care among neurology, ophthalmology, and primary care helps sort out what belongs to ADCA II versus another illness and guides safer treatment choices.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described unsteady gait, slurred speech, and shaky hand movements running through certain families. A grandparent who “wobbled” in later years, an aunt with sudden trouble with balance—these memories often hinted at a pattern long before doctors could name it. Families and communities once noticed patterns that seemed to skip no generation, with symptoms starting in mid-adulthood and gradually progressing over time.
First described in the medical literature as a familial form of slowly worsening balance problems, autosomal dominant cerebellar ataxia type II was initially recognized by its hallmark features: coordination difficulties, eye movement changes, and, in some families, vision issues linked to the retina. Early reports focused on what could be observed—how walking changed, how speech became less clear, and how quick, darting eye movements appeared—because there were no lab tests to confirm the diagnosis.
As medical science evolved, doctors learned that “autosomal dominant” inheritance meant each child of an affected parent has a 50% chance of inheriting the condition. Careful family trees and clinic notes showed how autosomal dominant cerebellar ataxia type II often appeared in each generation, though the age when symptoms began and how fast they progressed could vary widely. This variability sometimes led to confusion, with different names used for similar patterns across countries and clinics.
In recent decades, knowledge has built on a long tradition of observation. Brain imaging helped confirm that the cerebellum—the area that fine-tunes balance and coordination—was shrinking in many people with the condition. Eye specialists documented specific eye movement patterns and occasional retinal changes, adding detail to the clinical picture. These features helped distinguish type II from other inherited ataxias that can look similar at first glance.
Advances in genetics transformed the field. Genetic testing made it possible to identify the underlying cause in many families, provide clearer counseling about inheritance, and avoid years of uncertainty. Testing also showed that what once seemed like one rare disease actually represents a group of related conditions with overlapping symptoms. Despite evolving definitions, the core story has stayed consistent: a dominantly inherited ataxia that often begins in adulthood and gradually affects balance, speech, and eye control.
Today, the history of autosomal dominant cerebellar ataxia type II reflects the arc of modern medicine—from careful family stories and bedside exams to imaging and DNA analysis. Looking back helps explain why names and categories have shifted, and why getting the right label can still take time. That history also guides current care: earlier recognition, tailored genetic counseling, and focused support for movement, vision, and daily living.